PNC Financial Services Group’s Olema Pharmaceuticals OLMA Stock Holding History

PNC Financial Services Group’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.26K	Buy	580 +29	+5%	+$388	﹤0.01%	4240
2026 Q1	$8.21K	Hold	551	–	–	﹤0.01%	4039
2025 Q4	$13.8K	Sell	551 -166	-23%	-$2.95K	﹤0.01%	3823
2025 Q3	$7.02K	Buy	717 +1	+0.1%	+$6	﹤0.01%	4077
2025 Q2	$3.05K	Sell	716 -419	-37%	-$1.87K	﹤0.01%	4290
2025 Q1	$4.27K	Buy	1,135 +6	+0.5%	+$30	﹤0.01%	4118
2024 Q4	$6.58K	Sell	1,129 -153	-12%	-$1.53K	﹤0.01%	3950
2024 Q3	$15.3K	Sell	1,282 -132	-9%	-$1.69K	﹤0.01%	3634
2024 Q2	$15.3K	Buy	+1,414	New	+$15.3K	﹤0.01%	3605
2022 Q2	–	Sell	-1,202	Closed	-$5K	–	4651
2022 Q1	$5K	Buy	+1,202	New	+$6.62K	﹤0.01%	4006

Other funds holding OLMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

PNC Financial Services Group's OLMA Position: Q2 2026 in Review

PNC Financial Services Group increased its Olema Pharmaceuticals (OLMA) stake by 5.3% in Q2 2026, buying an estimated $388 and bringing the position to 580 shares worth $7.26K. The position accounts for ﹤0.01% of the portfolio, ranked #4240.

PNC Financial Services Group first reported a position in OLMA in Q1 2022 and has held it in 10 quarters since. The position peaked at $15.3K in Q3 2024. 45 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

PNC Financial Services Group held 580 shares of Olema Pharmaceuticals worth $7.26K as of Q2 2026.
PNC Financial Services Group bought 29 Olema Pharmaceuticals shares in Q2 2026, an estimated $388.
Olema Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4240 holding.
PNC Financial Services Group first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
PNC Financial Services Group's Olema Pharmaceuticals position peaked at $15.3K in Q3 2024.
45 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.